The Global Fluidics for Preclinical Market is expected to grow at a significant CAGR during the forecast period. The demand for advanced treatments has increased as the incidence of various illnesses and chronic disorders have increased. This has resulted in a rise in the number of cellular research on chronic diseases and their treatment, as well as the use of microfluidics and other technologies. According to the Organisation for Economic Co-operation and Development (OECD) Health at a Glance, 2019 study, over one-third of persons aged 15 and older in 27 OECD countries reported living with two or more chronic illnesses, such as cancer, heart attack, and stroke, chronic respiratory issues, and diabetes on average. The primary factor driving market expansion is the growing prevalence of chronic diseases surgeries, which accounts for the rising point of care demand.
A full report of Fluidics for Preclinical Market is available at: https://www.omrglobal.com/industry-reports/fluidics-for-preclinical-market
The growing need for high throughput screening techniques, low-volume sample analysis, In Vitro Diagnostics (IVD), and the development of innovative technologies such as advanced lab on chip technology are all contributing to the global fluidics for preclinical market growth globally. In September 2019, The Fluidigm Corporation, an American company, introduced the Advanta RNA-Seq NGS Library Prep Kit, a new microfluidics-based process for the production of RNA sequencing libraries. This method aims to broaden the applicability of the Juno Microfluidic System in high-throughput laboratories. Furthermore, in July 2020, the Fluidity OneW Serum has been launched by Fluidic Analytics in the UK. The new tool offers quantitative information on the antibody response to COVID19 that is difficult to get with standard antibody testing.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/fluidics-for-preclinical-market
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment covered
o By Type
o By Application
- Region covered
o North America
o Europe
o Asia-pacific
o Rest of world
- Competitive Landscape- Blacktrace Holdings Ltd., Fluigent SA, Halma Plc, Precigenome LLC, and PerkinElmer Inc.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Fluidics for Preclinical Market by Segments
By Product Type
- Software and Accessories
- Precision Syringe Pumps
By Application
- Life Science research
- Clinical Application
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
